Taken together, our data demonstrate, for the first time, that BC acts as an inhibitor of STS1 and STS2 phosphatase activities and highlight the functional roles of BC to enhance the expansion of HSPCs both in vitro and in vivo, suggesting its potential application in hematopoietic recovery. This evidence concerns the gene UBASH3B and breast cancer.